The 60-second version
Branched-chain amino acids (BCAAs) — leucine, isoleucine, and valine — built a CAD$3-billion-a-year supplement category on the claim that supplementing them spares muscle, builds muscle, and reduces soreness. The peer-reviewed evidence has steadily eroded each of those claims. The 2017 Journal of the International Society of Sports Nutrition consensus, the 2017 Wolfe review, and the 2021 Plotkin narrative review all converge on the same conclusion: BCAAs do almost nothing in adults consuming adequate dietary protein, because the muscle-building effect of leucine requires the other six essential amino acids to be present at the same time, which BCAAs alone don’t supply. Whey protein delivers the same leucine plus all the other amino acids for less money. The few populations who might benefit from BCAA supplements are quite specific: trained athletes performing extended fasted exercise, individuals with liver disease, and patients on certain restricted diets. For ordinary lifters, runners, and adults wanting to build muscle, BCAAs are an expensive way to flavour water. Save the money; buy whey, casein, or eat eggs.
What BCAAs are, and why supplement makers love them
BCAAs are three of the nine essential amino acids: leucine, isoleucine, and valine. They’re “branched-chain” because of their molecular structure (a side chain that branches off the main carbon backbone). Among the BCAAs, leucine is the central player: it activates the mTOR pathway that triggers muscle protein synthesis (MPS) Anthony 2000. The original 1980s research showing leucine could acutely boost MPS led, eventually, to the marketing claim that supplementing BCAAs would build muscle.
The supplement industry loves BCAAs because they’re cheap to manufacture, easy to flavour, and stack well into pre-workout, intra-workout, and post-workout products. The category sits around CAD$3 billion globally and has grown 5-7% annually for over a decade despite increasingly negative scientific consensus.
The evidence problem
The early BCAA research had a fatal flaw: nearly all of it was conducted in protein-undernourished or fasted subjects. When you give BCAAs to someone whose blood amino acid pool is depleted, MPS rises briefly. But this finding was extrapolated to claims about supplemented BCAAs in adults already eating adequate protein — and that extrapolation didn’t survive proper testing.
Wolfe’s 2017 review in the Journal of the International Society of Sports Nutrition looked at all published BCAA studies and concluded that BCAAs alone cannot drive a sustained increase in MPS because muscle-building requires all 9 essential amino acids to be available simultaneously Wolfe 2017. Leucine activates the mTOR signalling cascade, but if the other essential amino acids aren’t available, the synthesis machinery stalls. The cell sends the signal to build, then runs out of bricks.
“The claim that consumption of dietary BCAAs stimulates muscle protein synthesis or produces an anabolic response in human subjects is unwarranted.”
— Wolfe, J Int Soc Sports Nutr, 2017 view source
Head-to-head: BCAAs vs. whey protein
Plotkin and colleagues’ 2021 narrative review synthesizes the trial evidence comparing isolated BCAA supplementation to whey protein at matched leucine doses in resistance-trained adults Plotkin 2021. The pattern across the trials it reviews is consistent:
- Whey protein (~25 g, matched leucine): consistently produces significant gains in lean body mass and strength.
- Isolated BCAA supplementation: smaller gains, often not statistically distinguishable from placebo.
- Placebo (e.g. maltodextrin): gains attributable to training stimulus alone.
The mechanism behind that gap is acute, not just theoretical. BCAA ingestion alone does acutely increase myofibrillar protein synthesis and mTORC1 signalling after resistance exercise — roughly a 22% rise versus placebo — but that response is only about half of what a matched-leucine dose of whey protein produces, because the other essential amino acids whey supplies aren’t there to sustain it Jackman 2017. That undersized acute signal is consistent with the smaller long-term muscle-building gains isolated BCAA supplementation produces compared with whey.
Cost comparison: leucine per dollar
| Source | Leucine per serving | Total amino acid quality | Cost per ~3 g leucine (CAD) |
|---|---|---|---|
| Whey protein isolate (1 scoop = 25 g) | ~2.5-3.0 g | Complete (all 9 EAAs) | ~$0.80-1.20 |
| Casein protein (1 scoop = 25 g) | ~2.0-2.5 g | Complete | ~$1.00-1.40 |
| 3 large eggs | ~2.5 g | Complete | ~$1.00-1.50 |
| Greek yogurt (1 cup = 17 g protein) | ~1.6 g | Complete | ~$1.50-2.00 (for 3 g) |
| BCAA powder (1 scoop = 7 g) | ~3.0 g | Incomplete (missing 6 EAAs) | ~$1.50-3.00 |
| BCAA capsules | ~1.0-2.0 g per dose | Incomplete | ~$3.00-5.00 (for 3 g) |
BCAAs deliver leucine at 1.5-3× the cost of whey, with worse outcomes because they’re missing the other six essential amino acids. The math doesn’t favour them in any scenario where adequate dietary protein is being consumed.
Who actually might benefit from BCAAs
The literature supports a few specific populations:
- Trained athletes performing extended fasted exercise. Athletes who train fasted (early-morning sessions before any food) for 60+ minutes may experience a small benefit from intra-workout BCAAs in delaying central fatigue and reducing perceived effort Blomstrand 2006. The effect size is modest and disappears if any pre-workout food is consumed.
- Patients with liver disease. BCAA supplementation has documented benefit in cirrhosis, hepatic encephalopathy, and certain protein-restricted clinical contexts. This is a medical use under supervision, not a fitness application Marchesini 2003.
- Adults on protein-restricted diets for medical reasons. Phenylketonuria, certain kidney disease protocols, and other rare conditions sometimes use BCAA supplements as part of carefully managed nutrition plans — again, medical supervision required.
- Endurance athletes during ultra-distance events. The same central-fatigue mechanism described above (BCAAs competing with tryptophan for brain uptake) is the proposed basis for a fatigue benefit at very long durations (4+ hour events), though the effect is small Blomstrand 2006. Most ultra athletes using BCAAs for this purpose are getting minor benefit at best, if any.
Notably absent from the “might benefit” list: ordinary lifters, recreational runners, casual fitness enthusiasts, anyone consuming the recommended 1.2-2.0 g/kg/day of dietary protein, weight-loss dieters who eat protein at meals, and anyone using whey or casein as their primary supplement. For these populations, BCAAs are a category mistake.
What about reducing muscle soreness?
The DOMS (delayed-onset muscle soreness) reduction claim is the one BCAAs partially earn, but only under a specific protocol. Fouré and Bendahan’s 2017 systematic review of 11 human studies found that BCAA supplementation can reduce markers of exercise-induced muscle damage — but only when the damage itself was low-to-moderate, and the supplementation strategy involved a high daily BCAA intake (roughly 200 mg/kg/day or more) sustained for more than 10 days, ideally started before the damaging exercise Fouré 2017. That is a very different protocol from the single post-workout scoop most BCAA buyers actually take:
- The review found high heterogeneity across the 11 included studies, with only six rated as good quality.
- Benefit required a high daily dose sustained for 10+ days beforehand — not a single serving after an unaccustomed workout.
- Even under those conditions, the review describes the effect as conditional rather than a reliable, across-the-board reduction in soreness.
- The occasional, post-workout-only dosing pattern most people follow falls outside the protocol the review found any support for.
So under a specific high-dose, multi-week protocol, BCAAs may modestly reduce markers of muscle damage. Taken the way most people actually take them — a scoop mixed into water after a hard workout — the evidence doesn’t show that same benefit. The category-defining premise — that BCAA supplementation produces a unique, reliable soreness-reducing effect — isn’t supported.
Who BCAAs fit and who they don’t
| Profile | BCAA fit | Why |
|---|---|---|
| Adult eating 1.2+ g/kg protein daily | No | Diet already supplies abundant leucine + complete protein |
| Recreational lifter using whey post-workout | No | Whey already delivers leucine + all 9 EAAs |
| Adult on weight-loss diet eating protein at meals | No | Dietary protein covers needs; BCAAs add cost without benefit |
| Athlete training fasted (early AM, no breakfast) | Maybe | Modest benefit during the fasted session; eating something would work too |
| Endurance athlete in ultra-events | Maybe | Small fatigue benefit at very long durations |
| Patient with liver disease (under MD supervision) | Yes (medical) | Documented benefit; not a fitness use case |
| Patient on protein-restricted diet | Maybe (medical) | Specific clinical contexts only; physician decision |
If you currently take BCAAs
- Switch to whey protein at the same leucine dose. 25-30 g of whey delivers 2.5-3 g of leucine plus all 9 essential amino acids. Cost is comparable or lower per gram of leucine.
- Or eat 3-4 eggs / 1 cup Greek yogurt / 100 g chicken. Whole-food protein delivers the full amino acid profile with additional micronutrients.
- Time protein every 3-5 hours through the day. The MPS response to a meal saturates around 0.4 g/kg of protein; spacing matters more than total daily intake for muscle building Schoenfeld 2018.
- If you train fasted and want a small intra-workout boost: a small piece of fruit + a sip of whey delivers the same fatigue-mitigation effect for less cost.
- If you genuinely enjoy a flavoured drink during workouts: that’s a hydration win. The BCAA in it isn’t doing what the marketing says, but the act of drinking is real.
Practical takeaways
- BCAAs (leucine, isoleucine, valine) are 3 of the 9 essential amino acids. Building muscle requires all 9 to be available simultaneously — supplementing 3 isn’t enough.
- Plotkin 2021 (narrative review): across the trials it synthesizes, isolated BCAA supplementation produces muscle gains that are smaller than, and often statistically indistinguishable from, placebo, while whey protein at matched leucine produces significantly greater gains.
- Wolfe’s 2017 review: BCAAs alone cannot drive sustained increases in muscle protein synthesis in adults eating adequate protein.
- BCAAs can reduce exercise-induced muscle damage markers — but only at a high daily dose sustained for 10+ days before the damaging exercise, not from a single post-workout scoop.
- Whey protein delivers the same leucine + all other essential amino acids at roughly equivalent cost; food sources (eggs, yogurt, chicken) are cheaper still.
- Specific medical and ultra-endurance contexts have a real evidence base; ordinary lifters and runners don’t.
Frequently asked questions
Are BCAAs worth taking?
For almost all recreational lifters and runners, no. Plotkin’s 2021 narrative review found that isolated BCAA supplementation produces muscle gains equal to or only marginally better than maltodextrin placebo in resistance-trained men eating adequate protein, well below what whey protein produces. Wolfe’s 2017 review concluded BCAAs alone cannot drive sustained MPS because muscle building requires all 9 essential amino acids. Whey protein delivers leucine plus the other 8 EAAs at comparable cost.
Will BCAAs help me lose weight while preserving muscle?
Not meaningfully. The muscle-preserving effect of protein during weight loss comes from the complete amino acid profile and total protein dose, not BCAAs specifically. A protein-rich diet (1.6-2.2 g/kg during a deficit) preserves muscle. Adding BCAAs on top doesn’t add benefit; the leucine they contribute is already in the dietary protein.
What about during fasted morning workouts?
There’s a small evidence base for modest fatigue reduction during fasted training over 60 minutes. The effect is real but small, and it disappears if you eat anything pre-workout. A small piece of fruit + a sip of whey delivers the same effect more cheaply with a fuller amino acid profile.
BCAAs reduce soreness, right?
Conditionally. Fouré and Bendahan’s 2017 systematic review found BCAAs can reduce markers of exercise-induced muscle damage, but only with a high daily dose (roughly 200 mg/kg/day or more) sustained for more than 10 days before the damaging exercise — not from the single post-workout scoop most people actually take. The category-defining claim that BCAAs uniquely and reliably reduce soreness isn’t supported.
Are there any populations who should take BCAAs?
Yes — quite specific ones. Patients with liver disease (cirrhosis, hepatic encephalopathy) under physician supervision have a documented benefit. Adults on certain medical protein-restricted diets sometimes use BCAAs as part of carefully managed nutrition. Elite endurance athletes in ultra-distance events (4+ hours) may see modest fatigue benefits. Ordinary fitness enthusiasts aren’t in any of these groups.
References
Wolfe 2017Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? J Int Soc Sports Nutr. 2017;14:30. View source →Plotkin 2021Plotkin DL, Delcastillo K, Van Every DW, Tipton KD, Aragon AA, Schoenfeld BJ. Isolated leucine and branched-chain amino acid supplementation for enhancing muscular strength and hypertrophy: a narrative review. Int J Sport Nutr Exerc Metab. 2021;31(3):292-301. View source →Anthony 2000Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, Kimball SR. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr. 2000;130(10):2413-2419. View source →Jackman 2017Jackman SR, Witard OC, Philp A, Wallis GA, Baar K, Tipton KD. Branched-chain amino acid ingestion stimulates muscle myofibrillar protein synthesis following resistance exercise in humans. Front Physiol. 2017;8:390. View source →Blomstrand 2006Blomstrand E. A role for branched-chain amino acids in reducing central fatigue. J Nutr. 2006;136(2 Suppl):544S-547S. View source →Foure 2017Fouré A, Bendahan D. Is branched-chain amino acids supplementation an efficient nutritional strategy to alleviate skeletal muscle damage? A systematic review. Nutrients. 2017;9(10):1047. View source →Marchesini 2003Marchesini G, Bianchi G, Merli M, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003;124(7):1792-1801. View source →Shimomura 2010Shimomura Y, Inaguma A, Watanabe S, et al. Branched-chain amino acid supplementation before squat exercise and delayed-onset muscle soreness. Int J Sport Nutr Exerc Metab. 2010;20(3):236-244. View source →Schoenfeld 2018Schoenfeld BJ, Aragon AA. How much protein can the body use in a single meal for muscle-building? Implications for daily protein distribution. J Int Soc Sports Nutr. 2018;15:10. View source →Morton 2018Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376-384. View source →Phillips 2016Phillips SM. The impact of protein quality on the promotion of resistance exercise-induced changes in muscle mass. Nutr Metab (Lond). 2016;13:64. View source →Nair 2005Nair KS, Short KR. Hormonal and signaling role of branched-chain amino acids. J Nutr. 2005;135(6 Suppl):1547S-1552S. View source →Kim 2016Kim IY, Schutzler S, Schrader A, et al. The anabolic response to a meal containing different amounts of protein is not limited by the maximal stimulation of protein synthesis in healthy young adults. Am J Physiol Endocrinol Metab. 2016;310(1):E73-E80. View source →
